Evidence-based management of lipid disorders /

Mostrar otras versiones (1)
Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Vissers, Maud N., Kastelein, John J. P., Stroes, Erik S.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Harley : TFM, 2010.
Temas:
Lipids > Metabolism > Disorders > Treatment.
Evidence-based medicine.
Lipid Metabolism Disorders > therapy
Evidence-Based Practice
Evidence-Based Medicine
Médecine factuelle.
HEALTH & FITNESS > Diseases > General.
MEDICAL > Clinical Medicine.
MEDICAL > Diseases.
MEDICAL > Evidence-Based Medicine.
MEDICAL > Internal Medicine.
Evidence-based medicine
Acceso en línea:Texto completo
Tabla de Contenidos:
  • How much evidence is enough? / Daniel Steinberg
  • A brief review of lipoprotein metabolism / Martin Adiels [and others]
  • Epidemiological aspects of lipid and lipoprotein levels in relation to cardiovascular diseases / Jane Armitage, Louise Bowman, Sarah Lewington
  • Are LDL cholesterol-lowering functional food ingredients successful in the long term? / Jogchum Plat, Ronald P. Mensink
  • Evidence-based treatment of primary hypo- and hypercholesterolemic disorders / Tisha R. Joy, Robert A. Hegele
  • Does raising HDL protect against atherosclerosis? / Menno Vergeer, G. Kees Hovingh
  • How do we diagnose hypertriglyceridemia in clinical practice and what are the consequences for treatment? / Adie Viljoen, Anthony S. Wierzbicki
  • The optimal treatment of patients with familial combined hyperlipidemia / Evertine J. Abbink, Jacqueline de Graaf, Anton F. Stalenhoef
  • How to manage lipid and lipoprotein disorders in children / Serena Tonstad
  • Contribution of the atherogenic dyslipidemic phenotype to the increased cardiovascular disease risk of the metabolic syndrome and diabetes mellitus / Benoit J. Arsenault, Jean-Pierre Després
  • What are the consequences of renal insufficiency or the nephrotic syndrome for lipid levels? / Christiane Drechsler, Christoph Wanner, Ton Rabelink
  • The link between chronic inflammatory diseases and cardiovascular risk / Michael T. Nurmohamed
  • What is the evidence for a physiological and pathogenic role of lipoprotein (a)? / Sotirios Tsimikas
  • Sitosterolemia; xenophobia for the body / Shailendra B. Patel, Gerald Salen
  • How can we deal with inborn errors in cholesterol and bile acid biosynthesis? / Hester van Meer [and others]
  • Differential diagnosis of patients with xanthomas and xanthelasmata / Peter J. Lansberg
  • When should we fear statin interactions? / Rob E. Aarnoutse, David M. Burger
  • What are the considerations in patients who are statin 'intolerant'? / Frans L. Opdam, Henk-Jan Guchelaar, Jouke T. Tamsma.

Ejemplares similares